Additionally, we confirmed the finding of prior studies23,24 that volasertib causes apoptotic cell death (assessed by caspase 3/7 activity) in NSCLC cells (Supplementary Fig. 3). The gene discussed is CASP3; the disease is non-small cell lung carcinoma.